{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:20:21Z","timestamp":1774952421321,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.urolonc.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T22:33:27Z","timestamp":1759876407000},"page":"698.e1-698.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI score"],"prefix":"10.1016","volume":"43","author":[{"given":"Yuya","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halle","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Taneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Iwatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Potretzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2599-8183","authenticated-orcid":false,"given":"Fumihiko","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2025.09.006_bib0001","first-page":"350","article-title":"Upper tract urothelial carcinoma: epidemiology, high risk populations and detection","volume":"68","author":"Redrow","year":"2016","journal-title":"Minerva Urol Nefrol"},{"issue":"5","key":"10.1016\/j.urolonc.2025.09.006_bib0002","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","article-title":"Upper tract urothelial neoplasms: incidence and survival during the last 2 decades","volume":"164","author":"Munoz","year":"2000","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.09.006_bib0003","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","article-title":"The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.09.006_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2025.09.006_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and Adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and Future perspectives on Systemic therapy","volume":"79","author":"Leow","year":"2021","journal-title":"Eur Urol"},{"issue":"10232","key":"10.1016\/j.urolonc.2025.09.006_bib0006","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.urolonc.2025.09.006_bib0007","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant Nivolumab versus Placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.urolonc.2025.09.006_bib0008","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/jjco\/hyad118","article-title":"Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study","volume":"53","author":"Takahashi","year":"2023","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.09.006_bib0009","doi-asserted-by":"crossref","first-page":"l737","DOI":"10.1136\/bmj.l737","article-title":"Guide to presenting clinical prediction models for use in clinical settings","volume":"365","author":"Bonnett","year":"2019","journal-title":"Bmj"},{"issue":"10","key":"10.1016\/j.urolonc.2025.09.006_bib0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.urolonc.2025.09.006_bib0011","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00345-012-1008-9","article-title":"A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting","volume":"31","author":"Drouin","year":"2013","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.09.006_bib0012","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","article-title":"Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2025.09.006_bib0013","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.12631","article-title":"Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis","volume":"114","author":"Seisen","year":"2014","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2025.09.006_bib0014","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","article-title":"Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis","volume":"189","author":"Roupr\u00eat","year":"2013","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.09.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.08.021","article-title":"Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"39","author":"Abdul-Muhsin","year":"2021","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.09.006_bib0016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/iju.15321","article-title":"Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: results from a multicenter cohort study","volume":"31","author":"Suhara","year":"2024","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2025.09.006_bib0017","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.urolonc.2022.01.014","article-title":"The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: an extensive updated systematic review and meta-analysis","volume":"40","author":"Stangl-Kremser","year":"2022","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.09.006_bib0018","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.09.006_bib0019","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/bco2.117","article-title":"Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer","volume":"3","author":"Miura","year":"2022","journal-title":"BJUI Compass"},{"issue":"1","key":"10.1016\/j.urolonc.2025.09.006_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10147-023-02424-9","article-title":"Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study","volume":"29","author":"Kagawa","year":"2024","journal-title":"Int J Clin Oncol"},{"issue":"20","key":"10.1016\/j.urolonc.2025.09.006_bib0021","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3390\/cancers15204987","article-title":"Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review","volume":"15","author":"Bitaraf","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:17:36Z","timestamp":1763680656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925003576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1078143925003576"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.09.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI score","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}